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Introduction: Pulmonary arterial hypertension (PAH) is characterised by vascular 
remodelling of pulmonary arterioles. Disrupted iron homeostasis as well as subclinical 
haemolysis are implicated in PAH, although exact mechanisms remain unknown. IL-6, a 
proinflamatory cytokine and regulator of iron homeostasis is elevated in PAH patients and 
also been implicated in pulmonary vascular remodelling in murine models.  
Objectives: In this study we explored the influences of free haemoglobin (Hb) on 
proliferative responses and secondary mediator, IL-6 release in human pulmonary artery 
endothelial cells (hPAECs).  
Methods: Cells were challenged with Hb (10uM) and/or IL-6 (1-10ng/mL). Transcriptional 
regulation was analysed by RT-PCR, protein expression by immunocytochemistry, secretion 
by ELISA and proliferation by BrdU incorporation.  
Results: Novel findings demonstrate that Hb and IL-6 individually and in combination 
increased proliferation of hPAECs (by 32%, 47% and 63% respectively; p<0.05). CD163, a 
Hb scavenger receptor, was basally expressed as mRNA and protein (cell surface) on 
hPAECs and further modulated by Hb or IL-6 exposure. Hb treatment also caused increased 
transcription (30%; p<0.05) and release of IL-6 (107%; p<0.01) from hPAECs.  
Conclusion: This is the first report of Hb-mediated proliferation, CD163 expression and IL-6 
release in hPAECs with potential implications for autocrine and paracrine signalling in 
pulmonary vasculature. Hb uptake may be facilitated via CD163. These studies may provide 
novel insights regarding mechanisms for haemoglobin driven proliferative and second 
messenger responses of relevance to PAH. 
 
